Centre for Targeted Protein Degradation | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

245,041 results for “Centre for Targeted Protein Degradation”

Trials

View all 197282 →

A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer

103 participants · First posted Feb 16, 2024

Melatonin Degradation Rate in Human Milk

10 participants · First posted Jul 19, 2018

Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program

801 participants · First posted Jan 31, 2018

Drugs

View all 4477 →

target protein degradation therapeutic (Amphista)

E3 ubiquitin ligase based protein degradation

Protein degradation therapeutics(Boehringer Ingelheim/VantAI)

Organizations

View all 2404 →

Protein Sciences Corporation

United States

CENTRE FOR SIGHT

India

CENTRE FOR NEURO SKILLS

United States

News

View all 40878 →

Breakthrough in Protein Degradation Technology Reveals Molecular Mechanisms for Targeting 'Undruggable' Diseases

Innovative Approach to Cancer Treatment: Targeted Protein Degradation

Novel PROTAC Degrader ACBI3 Shows Efficacy Against Multiple KRAS Mutant Cancers

Page 1 of 24505